Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Sunshine Biopharma, Inc (SBFM) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Sunshine Biopharma, Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 1402328.
Total stock buying since 2015: $155,530.
Total stock sales since 2015: $0.
Total stock option exercises since 2015: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2024 | 20,000 | $2,000 | 0 | $0 | 0 | $0 |
| 2022 | 55,000 | $53,420 | 0 | $0 | 0 | $0 |
| 2016 | 253,082 | $50,110 | 0 | $0 | 0 | $0 |
| 2015 | 500,000 | $50,000 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2024-02 | 20,000 | $2,000 | 0 | $0 | 0 | $0 |
| 2022-11 | 30,000 | $22,920 | 0 | $0 | 0 | $0 |
| 2022-06 | 25,000 | $30,500 | 0 | $0 | 0 | $0 |
| 2016-04 | 253,082 | $50,110 | 0 | $0 | 0 | $0 |
| 2015-05 | 500,000 | $50,000 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-02-08 | Slilaty Steve N. (Chief Executive Officer) | Buy | 20,000 | .10 | 2,000 |
| 2022-11-30 | Sebaaly Camille (CFO/Secretary) | Buy | 30,000 | .76 | 22,920 |
| 2022-06-03 | Sebaaly Camille (CFO/Secretary) | Buy | 25,000 | 1.22 | 30,500 |
| 2016-04-12 | Slilaty Steve N. (Chief Executive Officer) | Buy | 253,082 | .20 | 50,110 |
| 2015-05-27 | Slilaty Steve N. (Chief Executive Officer) | Buy | 500,000 | .10 | 50,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of SBFM listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Sunshine Biopharma, Inc (symbol SBFM, CIK number 1402328) see the Securities and Exchange Commission (SEC) website.